A team of doctors and scientists have found "clear evidence" of a cause of neurodegeneration in people with Alzheimer’s disease."Changes in the orchestration of brain oxygenation dynamics and neuronal ...

A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

Scientists led by the Institute of Nanotechnology in Italy, in collaboration with the ESRF, the European Synchrotron in ...

Scientists have used advanced X-ray phase-contrast tomography (XPCT) to uncover how gut health may influence Alzheimer’s disease.

In a bid to revolutionize Alzheimer’s detection, scientists have examined the brain’s neurovascular unit. The research ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease ... on medications that shrink the sticky brain deposits of a protein called amyloid ...

New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms can overlap between diabetes and dementia.

protein accumulation in the brain. These Aβ proteins are a telltale biomarker of Alzheimer’s disease. In January of 2023, the FDA provided accelerated approval to a second anti-Aβ monoclonal ...

Research in rodents has largely shown that these types of diabetes and obesity drugs, which mimic metabolic hormones, can improve several hallmarks of Alzheimer’s disease in the brain ...

Alzheimer’s disease is a dominant form of dementia, representing 60 to 70 percent of cases. Recent approvals by the Food and Drug Administration have focused on medications that shrink the sticky ...